Pacer Advisors
ANGO icon

Pacer Advisors’s AngioDynamics ANGO Stock Holding History

Pacer Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,427
Closed -$34K – 945
2020
Q1 		$34K Sell
3,427
-4,576
-57% -$57.4K ﹤0.01% 569
2019
Q4 		$128K Buy
8,003
+371
+5% +$5.67K 0.01% 1138
2019
Q3 		$141K Buy
+7,632
New +$149K ﹤0.01% 1107
2018
Q2 		– Sell
-1,054
Closed -$18K – 1170
2018
Q1 		$18K Buy
1,054
+238
+29% +$3.97K ﹤0.01% 1019
2017
Q4 		$14K Sell
816
-349
-30% -$5.96K ﹤0.01% 1121
2017
Q3 		$20K Buy
1,165
+341
+41% +$5.73K ﹤0.01% 1160
2017
Q2 		$13K Buy
+824
New +$13K ﹤0.01% 1198

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Pacer Advisors's ANGO Position: Q2 2020 in Review

Pacer Advisors sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 3,427 shares — an estimated $34K sold.

Pacer Advisors first reported a position in ANGO in Q2 2017 and held it in 7 quarters. The position peaked at $141K in Q3 2019. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

  • Pacer Advisors reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
  • Pacer Advisors sold 3,427 AngioDynamics shares in Q2 2020, an estimated $34K.
  • Pacer Advisors first reported a position in AngioDynamics in Q2 2017 and held it in 7 quarters.
  • Pacer Advisors's AngioDynamics position peaked at $141K in Q3 2019.
  • 146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Pacer Advisors's 13F filing for Q2 2020, filed 29 Jul 2020.